Obermatt
See Similar Stocks →

Flags

Earnings warning

LENSAR

NAQ:LNSR · US52634L1089
Health Care Equipment & SuppliesSmall

360

88
Profit price28
Owner Earnings Yield100
Dividend Yield1
Price/Sales83
EV / Gross Profit72
Price/Book10
Return on Capital9
Cash Return on Capital100
Return on Equity100
EBIT Margin34
Gross Profitability54
Cash Conversion8
Accruals3
Owner Earnings Margin100
Sales growth35
Profit growth60
Reinvestment10
Price momentum12
Debt load69
Refinancing88
Debt Payback100
Liquidity65
Analyst ratings100
Opinion Changes50
Price Target Upside33
Market mood53
Value Creation17/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

LENSAR generates returns well above its cost of capital, the foundation of durable shareholder value.

Based on 3/5 components.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2004
Employees110
Websitelensar.com
ISINUS52634L1089
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Augmented RealityArtificial IntelligenceOphthalmologySurgeryBiomedical EngineeringHealth CareHospitalMedical Device

Description

LENSAR, Inc. is a commercial-stage medical device company. The company is focused on designing, developing, and marketing advanced laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmat…

Analysis

Middle-of-the-road

LENSAR, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 2.1×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is sturdy. The company scores 17/20 on our value-creation score: strong value creator. Analysts lean positive.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
66
2026

All-time high

78

Mar 2026

All-time low

66

Jun 2026

Average rank

72

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
83
—
—
—
Price/Earnings
57
—
—
—
Price/Book
10
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
48
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare LENSAR with its peers
Nov
NYQ:NOV
39
CountryUSA
IndustryEnergy Equipment & Services
SizeX-Large
Full Stock Analysis →
Forian
NAQ:FORA
23
CountryUSA
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
AMC Robotics
NAQ:AMCI
1
CountryUSA
IndustryElectronic Equipment, Instruments & Components
SizeX-Small
Full Stock Analysis →
Pulse Biosciences
NAQ:PLSE
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Caris Life Sciences
NSQ:CAI
93
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
VisionWave
NMQ:VWAV
—
CountryUSA
IndustryAerospace & Defense
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →